A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT05705271
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT05705271
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT05705271. Allocation not applicable; no masking; primary purpose treatment. Start 2023-02-08 (actual); primary completion 2025-07-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
- Condition
- Chronic Kidney Disease
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Finerenone (Kerendia, BAY94-8862)
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct05705271- Content hash
4d74c10f0319fe43b709827eff3729134463deaf258e610719202110a7a9509d